Bayer Zydus Pharma is a joint venture company in India. Bayer Healthcare and Zydus Cadila came together to form Bayer Zydus Pharma, which focuses on meeting up patients need. Key elements of Bayer Zudus pharma in the Indian market are metabolic disorders, women’s healthcare, diagnostic imaging, oncology, cardiovascular diseases, and anti-diabetic treatments.

In the General Medicine unit, the company offers products for prevention of myocardial infarction and stroke, control of high blood pressure, for diabetes management and also, offers active ingredients to treat respiratory and urinary tract infections i.e. bacterial infections. The Bayer Zydus Pharma Company is a world leader in the Women’s Healthcare business unit on three main categories such as menopause management, contraception, gynecological therapies, and female hormonal oral contraceptives.

Bayer Zydus Pharma is active towards a social cause. The company runs programs such as Improving Lives and Enabling Better Treatment, Patient Assistance Program, and Happy Life Initiative, etc. Through programs, the company works for different issues.

Improving Lives and Enabling Better Treatment program by the company, mainly makes innovative medicines available to fight against neglected diseases and helps in modern family planning. Another program by the company, Patient Assistance Program (PAP) reduces the cost of the monthly treatment.